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Abstract The distribution of type II and VI collagen was
immunocytochemically investigated in bovine articular and
nasal cartilage. Cartilage explants were used either fresh or
cultured for up to 4 weeks with or without interleukin 1a
(IL-1a). Sections of the explants were incubated with
antibodies for both types of collagen. Microscopic analyses
revealed that type II collagen was preferentially localized
in the interchondron matrix whereas type VI collagen was
primarily found in the direct vicinity of the chondrocytes.
Treatment of the sections with hyaluronidase greatly
enhanced the signal for both types of collagen. Also in
sections of explants cultured with IL-1a a higher level of
labeling of the collagens was found. This was apparent
without any pre-treatment with hyaluronidase. Under the
influence of IL-1a the area positive for type VI collagen
that surrounded the chondrocytes broadened. Although the
two collagens in both types of cartilage were distributed
similarly, a remarkable difference was the higher degree of
staining of type VI collagen in articular cartilage. Con-
comitantly we noted that digestion of this type of cartilage
hardly occurred in the presence of IL-1a whereas nasal
cartilage was almost completely degraded within 18 days
of culture. Since type VI collagen is known to be relatively
resistant to proteolysis we speculate that the higher level of
type VI collagen in articular cartilage is important in pro-
tecting cartilage from digestion.
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Introduction
The extracellular matrix of hyaline cartilage contains a
wide variety of non-collagenous proteins and several types
of collagen. Of these collagens type II is the main com-
ponent and constitutes about 80–95% of the total amount of
collagen. In addition small amounts of type VI (1–2%),
type IX (1%) and type XI (3%) are present (Chang et al.
1997; Poole et al. 1988; Smith et al. 1989). Type II col-
lagen is essential for the structural integrity of the tissue,
whereas the other collagens are likely to play a role in
cellular attachment, fibril formation and/or the three
dimensional organization of cartilage (Billinghurst et al.
1997). Of these collagens, type VI collagen is of consid-
erable interest since it is assumed to function as an
anchoring meshwork that connects cells to their sur-
rounding environment (Everts et al. 1998; Kuo et al. 1997).
Type VI collagen is composed of three genetically dif-
ferent a chains that form triple helices with globular ter-
minal domains. Repeats that have homology with the
collagen-binding domain of von Willebrand factor are
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present in the globular domains and the triple helical part
of the molecule contains at least 11 RGD sequences (Kuo
et al. 1995; Lamande et al. 1998; Marcelino and McDevitt
1995). The multi-domain structure of type VI collagen not
only makes it suitable for an interaction with components
of the extracellular environment like collagen type II,
decorin, fibromodulin, hyaluronan, and fibronectin, but also
interacts with the cell surface by its integrin-binding
properties (Loeser 1997, 2000). In line with its possible
interaction with cells relatively high levels of type VI
collagen have been observed in the pericellular environ-
ment of the chondrocyte (Chang and Poole 1996; Chang
et al. 1997; Hagiwara et al. 1993; Hambach et al. 1998;
Poole et al. 1992).
Although numerous studies have shown metabolism of
collagen type II, hardly anything is known about synthesis
and breakdown of type VI collagen in cartilage (Aigner
et al. 1997; Billinghurst et al. 1997; Dodge and Poole 1989;
Freemont et al. 1999; Kozaci et al. 1997; Nelson et al.
1998; Pullig et al. 1999; Stoop et al. 1999). It has been well
established that under pathological conditions, such as
osteoarthritis or rheumatoid arthritis the major part of the
cartilage is broken down. Proteolytic enzymes, in particular
matrix metalloproteinases and ADAMs (a disintegrin and
metalloproteinase), mediate this degradation (Bohm et al.
1999; Flannery et al. 1999; McKie et al. 1997). Yet, several
data indicate that type VI collagen is rather resistant to
proteolytic attack (Kielty et al. 1993; Okada et al. 1992). In
this respect it is of interest that in osteoarthritic cartilage
higher levels of type VI collagen with a broader pericel-
lular distribution have been noted (Arican et al. 1996;
McDevitt et al. 1988; Poole et al. 1992; Ronziere et al.
1990). This increased amount has been suggested to be due
to an elevated synthesis of type VI collagen (Hambach
et al. 1998). An alternative possibility, however, is that
type VI collagen was already present in these areas but
masked by other matrix components. A (partial) break-
down of the latter constituents may result in accessibility of
the antigenic sites of type VI collagen, thus making
immunodetection possible (Dreiling et al. 2002a, b).
In the present study we investigated this by analyzing
sections of cartilage that were either incubated with hyal-
uronidase or obtained from explants cultured with inter-
leukin 1a (IL-1a), a cytokine known to induce digestion of
cartilage (Xu et al. 1996). We compared two types of
hyaline cartilage, nasal and articular, since it has been
established that cartilage type-dependent differences exist
in the IL-1a-induced degradation. In articular cartilage
breakdown of type II collagen hardly occurs in the pres-
ence of IL-1a whereas this type of collagen is readily
digested in nasal cartilage (Ellis et al. 1994; Kozaci et al.




A low level of positively stained type II collagen was found
in sections of non-cultured articular cartilage localized in
the direct vicinity of the cells. In the interterritorial matrix
between the chondrons it was present in a punctate pattern
(Fig. 1a). Treatment of the sections with hyaluronidase
resulted in a more intense staining of type II collagen
around the chondron (Fig. 1b).
In explants cultured in control medium a similar dot-like
labeling was seen (Fig. 2a). Treatment with hyaluronidase
resulted in a more intense staining around the chondrons
Fig. 1 Localization of collagen type II in bovine articular cartilage.
Cartilage sections were obtained form non-cultured explants and
incubated with an antibody against type II collagen which was
followed by a FITC-labeled second antibody. The sections were
treated or not with hyaluronidase for 55 h. a without Hyaluronidase
treatment (-hyal). Type II collagen label is present in a dot-like
appearance (arrows). b with hyaluronidase treatment (?hyal). After
hyaluronidase treatment the dot-like pattern is lost and the labeling is
more uniformly distributed with a more intense staining around the
chondron (arrows). In control sections incubated with buffer for 55 h
the dot-like distribution was similar to that seen in untreated sections.
Bars: 0.2 lm
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(Fig. 2b). Culturing in the presence of IL-1a, however,
resulted in uniform labeling and around the chondron
(perichondral), a more intense staining was apparent.
Treatment with hyaluronidase had no additional effect on
the localization of type II collagen (Fig. 3a, b). The change
in labeling pattern was already apparent after 1 week of
culturing with IL-1a.
Nasal cartilage
In non-cultured nasal cartilage a low level of labeled type
II collagen was found in the direct vicinity of the chon-
drocytes and in the interchondral area. Comparable with
the articular cartilage explants, also in nasal cartilage the
label had a dot-like appearance (not shown).
The over-all localization in sections of explants cultured
in control medium was similar to that found in sections of
non-cultured explants. Culturing with IL-1a changed the
labeling pattern considerably. As with articular cartilage
the dot-like labeling changed in a more uniform distribu-
tion already after a culture period of 1 week (Fig. 4a, b).
Time intervals later than 2 weeks could not be studied
since after 18 days of culturing in the presence of IL-1a the
nasal cartilage explants were digested completely.
Comparable to the labeling found in articular cartilage,
hyaluronidase pre-treatment resulted in a uniform distri-
bution of type II collagen labeling. Treatment with hyal-
uronidase of sections of explants cultured with IL1a did not
augment the staining intensity (Fig. 4b). Labeling of con-
trol sections pre-treated with buffer did not differ from
untreated sections.
A striking difference between the two types of cartilage
was the lack of any notable digestion of articular cartilage in
the presence of IL-1a. Even after 4 weeks of culturing in the
presence of the cytokine, the articular explants appeared to
be intact and type II collagen could be detected easily.
Under all conditions a more intense labeling was found in
articular cartilage compared to nasal cartilage explants.
Type VI collagen
Articular cartilage
In articular cartilage sections obtained from non-cultured
explants, type VI collagen was found as a distinct broad
Fig. 2 Localization of collagen type II in sections obtained from
articular cartilage explants cultured for 1 week without IL-1a. Before
labeling some sections were treated with hyaluronidase for 55 h. a
without hyaluronidase treatment (-hyal). b with hyaluronidase.
(?hyal) Treatment with hyaluronidase resulted in a more intense
staining around the chondrons. Bars: 0.2 mm
Fig. 3 Localization of collagen type II in sections from articular
explants cultured for 1 week with IL-1a. Before labeling some
sections were treated with hyaluronidase for 55 h. a without
hyaluronidase treatment (-hyal) b with hyaluronidase treatment
(?hyal). Culturing in the presence of IL-1a resulted in a change of the
localization of type II collagen: the dot-like labeling became more
uniform and around the chondron (perichondral) a more intense
staining was apparent. Treatment with hyaluronidase had no
additional effect on the localization of type II collagen. Bars: 0.2 mm
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band surrounding the chondrocytes (Fig. 5a–d). A rela-
tively weak labeling was present between the cells of a
chondron and some labeling was found interchondrally.
In sections of cultured control explants the site and
amount of type VI collagen labeling was similar to non-
cultured cartilage (Fig. 6a). A 1 week incubation with
IL-1a had no effect on the distribution of type VI colla-
gen (Fig. 6b) but after 4 weeks of culturing with IL-1a a
higher level of label was found within and between the
chondrons (Fig. 6d). The broad area of label surrounding
the chondron changed into a thinner more intensely
stained area. Also the interchondral labeling appeared to
be more intense. Treatment of the sections of cultured
control explants with hyaluronidase (Fig 6c, d) mimicked
the results obtained following culturing with IL-1a
(Fig. 6d). Also in the hyaluronidase treated sections the
broad positive area surrounding the chondrons appeared
to be as a more intense but narrower positively staining
band.
Nasal cartilage
The distribution pattern of type VI collagen in sections of
nasal cartilage (Fig. 7a–d) was comparable to the one
found in articular cartilage. This was the case for sections
of non-cultured explants as well as for explants cultured
without IL-1a (Fig. 7a, c) or with the cytokine (Fig. 7b, d)
and also for hyaluronidase-treated sections (Fig. 7c, d).
However, the intensity of staining proved to differ con-
siderably. In all sections of articular cartilage a more pro-
nounced labeling of type VI collagen was apparent
(compare Fig. 7 with Fig. 6).
Fig. 5 Localization of collagen
type VI in non-cultured articular
cartilage explants. Before
labeling the sections were a, b
without hyaluronidase treatment
(-hyal) c, d with hyaluronidase
treatment (?hyal). a, b A high
labeling intensity is apparent in
the direct vicinity of the
chondrocytes (arrows) and
some labeling is seen
interchondrally. c, d Treatment
with hyaluronidase resulted in a
narrower but more intense
staining area in between the
chondrons (arrows). Bars:
0.2 mm
Fig. 4 Localization of type II collagen in nasal cartilage cultured for
1 week with IL-1a. In a without hyaluronidase treatment (-hyal). b
with hyaluronidase treatment (?hyal). Note the uniform labeling of
type II collagen in nasal explants following culturing in the presence
of IL-1a. Hyaluronidase proved to have no additional effect on type II
collagen stainability. Bars: 0.2 mm




Hardly any gelatinolytic activity was detectable in media
obtained from articular cartilage explants that were
cultured for up to 4 weeks without IL-1a (Fig. 8a, lanes
1–4). Also in cultures with IL-1a during the first 2 weeks
gelatinolytic activity was not increased (Fig. 8a, lanes 1, 2
with IL-1a). At the 3 and 4 week time points, however,
activity of MMP-2 and -9 became apparent (Fig. 8a, lanes
3, 4 with IL-1a). In particular the level of pro-MMP-9
was increased.
Nasal cartilage
In contrast to articular cartilage, zymographic analysis of
conditioned media obtained from nasal cartilage cultured in
the absence of IL-1a revealed that at all culture time
intervals studied MMP-2 and -9 were detectable (Fig. 8b,
lanes 1–4). Only the proform of these enzymes proved to
be present.
In the presence of IL-1a (Fig. 8b, lanes 1–4 with IL-1a),
not only the proform but also the active form of the
enzymes could be detected. This was particularly apparent
after 3 and 4 weeks of culture. At all time intervals more
gelatinolytic activity was present in the media of nasal
cartilage than in that of articular cartilage.
Discussion
In line with findings presented previously by others
(Bruckner and van der Rest 1994; Cremer et al. 1998; Eyre
2002) hyaline cartilage contains both type II and VI col-
lagen. We now show that this is the case for both types of
hyaline cartilage studied, nasal and articular cartilage. Yet,
differences in labeling intensity were noted among the two
types. Articular cartilage stained much more intense with
the two collagen antibodies than nasal cartilage did. Also
following incubation with hyaluronidase or culturing with
IL-1a, a more intense staining was apparent in articular
cartilage compared to nasal cartilage. This finding strongly
suggest that articular cartilage contains more of collagens
type II and VI than nasal cartilage. The difference in
composition of the two types of cartilage could perhaps be
related to functional differences between the two cartilage
types. The main function of nasal cartilage is to provide
support whereas articular cartilage is essential in with-
standing forces and wear in joints. It is not unlikely that
such extreme functional demands of articular cartilage are
reflected in higher levels of collagens that provide the
necessary tensile strength to the tissue.
The highest level of type II collagen in cartilage was
found interchondrally. Incubation of the sections with
hyaluronidase resulted in enlargement of the positively
stained areas. This finding indicates that under normal
conditions a relatively large fraction of type II collagen is
Fig. 6 Localization of type VI collagen in articular cartilage cultured
for 1 or 4 weeks a, b without hyaluronidase treatment (-hyal) c, d
with hyaluronidase treatment (?hyal) a, c cultured without IL-1a
(-IL-1a) b, d cultured with IL-1a (?IL-1a) Culturing in the presence
of IL-1a resulted in a more intense staining. This was found both for
the area in the direct vicinity of the chondrocytes (arrows) as well as
for the interchondral areas (asterisks). Hyaluronidase treatment (c, d)
also resulted in a more intense staining. In the direct vicinity of the
chondron a narrow band of intense staining for type VI collagen is
present. At some distance an unstained area is followed by an intense
staining interchondral area. This staining pattern is found both after
hyaluronidase treatment and after culture with IL-1a. Bars: 0.2 mm
J Mol Hist (2010) 41:9–17 13
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not accessible for the antibody. A comparable result was
reached by culturing the cartilage explants with IL-1a.
Under the influence of this cytokine proteoglycans are
digested (Flannery et al. 1999; Xu et al. 1996) thus
resulting in accessible antibody recognition sites. In this
respect our data are in line with studies performed by
others (Arican et al. 1996; Bathon et al. 1994) and dem-
onstrate that large fractions of the collagen present in
cartilage are masked by non-collagenous components.
A notable finding with respect to the localization of type
VI collagen was its shift from a broad pericellular to a more
intensely staining narrow band following culturing with
IL-1a. Although this may suggest that under the influence
of IL-1a a higher level of type VI collagen is produced,
Bathon and coworkers (1994) demonstrated that this
cytokine suppresses the expression of type VI collagen by
chondrocytes. Therefore, a more plausible explanation is
that due to IL-1a-induced loss of extracellular matrix
constituents, a rearrangement of type VI collagen occurred.
Data presented by Arican et al. (1996) support this
view since they demonstrated a similar redistribution in
osteoarthritic cartilage.
The highest levels of type II collagen were found at
some distance from the chondrocytes whereas in the direct
vicinity of the cells type VI collagen prevailed (Poole et al.
1988, 1992). The presence of the latter collagen in the
direct vicinity of the cells has prompted the suggestion that
a direct interaction exists between chondrocytes and type
VI collagen (Marcelino and McDevitt 1995; Sherwin et al.
1999; Soder et al. 2002). Since it has been well established
that collagens greatly affect the activity of cells, among
which the expression and activity of enzymes like MMPs
(Flannery et al. 1999; Kerkvliet et al. 2003; Ohta et al.
1998; Okada et al. 1992), a close association of the chon-
drocytes with this type of collagen may be important in the
modulation of chondrocyte activity.
The presently described difference in the level of type
VI collagen in close vicinity to chondrocytes of articular
cartilage (high level) and nasal cartilage (low level) may
provide an explanation for the difference in digestion of
these two types of cartilage. In the present and in previous
studies (Dodge and Poole 1989; Kozaci et al. 1997; Xu
et al. 1996) it was shown that under the influence of IL-1a a
complete digestion of nasal cartilage occurred within
2 weeks. Articular cartilage, however, proved highly
resistant to IL-1a-induced digestion. Even after 4 weeks of
culturing hardly any sign of degradation was noted. The
difference in digestion was also expressed in the level of
MMP-2 and -9 as assessed by zymography. A possible
explanation for the observed resistance to digestion could
be the relatively high level of type VI collagen in articular
cartilage. Type VI collagen has been shown to resist
digestion by many proteolytic enzymes (Kielty et al. 1993;
Xu et al. 1996). A protective role of type VI collagen has
been suggested previously by Horikawa et al. (2004).
These authors found an accumulation of type VI collagen
Fig. 7 Localization of collagen type VI in sections from nasal
cartilage explants cultured for 2 weeks with or without IL-1a. The
sections were treated with or without hyaluronidase. a, b without
hyaluronidase treatment (-hyal) c, d with hyaluronidase treatment
(?hyal) a, c 2 week culture period without IL-1a (-IL-1a) b, d
2 week culture period with IL-1a (?IL-1a) Type VI collagen staining
is present in a broad area around the chondrocytes (arrows).
Treatment with hyaluronidase (c) resulted in a smaller but more
intense staining area in between the chondrons (arrows). After a
2 week culture period with IL-1a (b, d), the distribution of type VI
collagen is similar to that found in c following hyaluronidase
treatment. Also here an intensively stained narrow area around the
chondron (arrows) is next to a narrow unstained area. Interchondrally
the staining becomes more intense after IL-1a incubation or
hyaluronidase treatment. After 2 weeks culturing with IL-1a the
explant is nearly completely digested. Bars: 0.2 lm
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in the pericellular environment of chondrocytes after
addition of TGF-b. Since this growth factor plays a bene-
ficial role in preventing progression of osteoarthritis, they
suggested that type VI collagen played a protective role.
We now propose that the digestion of different types of
hyaline cartilage (partially) depends on the amount of type
VI collagen present; the higher the amount the more
resistant to degradation.
Experimental procedures
Culture of cartilage explants
Cartilages from bovine nasal septa and metacarpophalan-
geal joints were cut into fragments of an average weight of
30 mg, washed with phosphate buffered saline (PBS) and
cultured in serum-free Dulbecco’s modified Eagle’s
medium (DMEM; Invitrogen, Paisley, UK), containing
glutamine (2 mM), penicillin G (2,000 units/ml), strepto-
mycin (0.1 mg/ml) and Hepes (10 mM) (all from Invitro-
gen). The explants were cultured for up to 4 weeks in 48
well tissue culture plates (Costar, High Wycombe, UK) at
37C in a humidified atmosphere of 5% CO2 and 95% air.
Each well contained two cartilage explants in 400 ll of
medium.
Series of explants were incubated for various time
intervals with recombinant IL-1a at a concentration of
50 ng/ml (Kozaci et al. 1997). Conditioned media were
frozen and stored at -20C for zymographic analysis.
Cartilage explants were embedded in Tissuetek and frozen
at -80C until used for cryosectioning. Control cartilage
explants were either not cultured and embedded immedi-
ately or cultured in DMEM only.
Immunolocalization of type II and type VI collagen
Cryosections of 8 lm were cut on a motor driven Bright
cryotome at a cabinet temperature of -25C. Sections were
collected on Vectabond coated slides (Vector Laborato-
ries Inc., Burlingame, CA). Sections were either directly
incubated for immunolocalization or first treated with
hyaluronidase (from bovine testis, Sigma Chemical Co.
St.Louis, MO), in a concentration of 5 mg/ml in 0.1 M
sodium acetic acid and 0.15 M NaCl buffer (pH 5.2) for
55 h at 4C. Control sections were incubated with buffer
only. To prevent drying of the sections, a Teflon ring was
placed around the sections. The ring was fixed with vac-
uum grease and covered by a coverslip. The sections were
incubated in a humidified environment. In preliminary
experiments sections were treated with hyaluronidase for
different time intervals and analyzed for the presence of
proteoglycans by Safranin O staining. A complete loss of
staining was found after 55 h of hyaluronidase treatment,
indicating that most if not all proteoglycans were lost by
this enzyme incubation.
The cryosections were washed with PBS and fixed for
10 min with 4% formaldehyde in 0.15 M phosphate buffer.
Free aldehyde groups were blocked with phosphate-buf-
fered glycine (50 mM). After a 10 min wash in PBS con-
taining 1% bovine serum albumin (BSA) the sections were
incubated for 2 h with goat anti-human type II or type VI
collagen antibody (Southern Biotechnology Associates Inc.,
Birmingham, AL) in a final concentration of 8 or 52 lg/ml
in PBS, respectively. Control sections were incubated with
similar concentrations of non-immune goat IgG (Southern
Biotechnology Associates Inc.). The sections were washed
with PBS/BSA for 10 min and incubated for 1 h with FITC-
conjugated rabbit anti-goat IgG (Southern Biotechnology
Associates Inc.) in a concentration of 7 lg/ml. Nuclei were
counterstained with propidium iodide. Sections were
- IL-1 + IL-1
4
-IL-1 +IL-1
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Fig. 8 Zymography of conditioned medium of: a Articular cartilage
cultured for up to 4 weeks with or without IL-1a. b Nasal cartilage
cultured for up to 4 weeks with or without IL-1a. But after 18 days of
culture with IL-1a the nasal cartilage explant is nearly completely
digested. The numbers 1–4 refer to the weeks of culturing. Hardly any
gelatinolytic activity was detectable in media obtained from articular
cartilage explants cultured without IL-1a or cultured for 1 or 2 weeks
with IL-1a (panel A, lanes 1, 2, 3, 4 without IL-1a and lanes 1, 2 with
IL-1a, respectively). Longer culture periods with IL-1a resulted in a
detectable release of the pro- and active form of MMP-2 (72 and 68
kD, respectively) and MMP-9 activity in the media (panel A, lanes 3,
4 ?IL-1a). The overloaded bands likely express MMP-9 in its pro-
and mature form (92 and 88 kD, respectively). The same bands are
present in the nasal cultures (panel B), but they are much more
pronounced in the medium obtained from this type of cartilage after 3
and 4 weeks of culture with IL-1a
J Mol Hist (2010) 41:9–17 15
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washed with PBS/BSA and mounted in Vectashield (Vector
laboratories Inc. Burlingame, CA) and fluorescent staining
was viewed with a Leica-DMRA microscope. Micrographs
were made using Kodak Ektachrome 400 ASA film. The
negatives were scanned to digitalize the pictures.
Zymography
To assess the level of gelatinolytic activity in conditioned
media of cultured explants, gelatin zymography was per-
formed. Five micro litre of conditioned medium was 1:1
diluted with sample buffer (0.1 M Tris–HCL, 4% SDS,
20% glycerol, 0.005% bromophenol blue, 10 mM EDTA)
and electrophoresed through a 10% polyacrylamide gel
containing 2% gelatin, as described by (Heussen and
Dowdle 1980). After electrophoresis, gels were washed in a
50 mM Tris–HCl buffer (pH 7.5) containing 2.5% Triton
X-100 and 5 mM CaCl2 and subsequently incubated at
37C, in Tris–HCL buffer (pH 7.5) supplemented with
5 mM CaCl2, 1% Triton X-100 and 0.02% NaN3.
Following 18 h incubation, gels were stained with 0.1%
Coomassie Brilliant Blue and cleared with 7% acetic acid
with 4% methanol to visualize unstained proteolytic bands.
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